- Home
- REPL vs GHM Comparison
REPL vs GHM Comparison
Compare REPL & GHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- GHM
- Stock Information
- Founded
- REPL 2015
- GHM 1936
- Country
- REPL United States
- GHM United States
- Employees
- REPL N/A
- GHM N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- GHM Industrial Machinery/Components
- Sector
- REPL Health Care
- GHM Industrials
- Exchange
- REPL Nasdaq
- GHM Nasdaq
- Market Cap
- REPL 547.0M
- GHM 577.9M
- IPO Year
- REPL 2018
- GHM N/A
- Fundamental
- Price
- REPL $5.80
- GHM $49.23
- Analyst Decision
- REPL Hold
- GHM Strong Buy
- Analyst Count
- REPL 9
- GHM 2
- Target Price
- REPL $7.00
- GHM $60.00
- AVG Volume (30 Days)
- REPL 2.5M
- GHM 76.1K
- Earning Date
- REPL 11-11-2025
- GHM 11-07-2025
- Dividend Yield
- REPL N/A
- GHM N/A
- EPS Growth
- REPL N/A
- GHM 184.08
- EPS
- REPL N/A
- GHM 1.26
- Revenue
- REPL N/A
- GHM $215,432,000.00
- Revenue This Year
- REPL N/A
- GHM $10.98
- Revenue Next Year
- REPL $408.25
- GHM $10.59
- P/E Ratio
- REPL N/A
- GHM $38.87
- Revenue Growth
- REPL N/A
- GHM 14.64
- 52 Week Low
- REPL $2.68
- GHM $24.78
- 52 Week High
- REPL $17.00
- GHM $58.00
- Technical
- Relative Strength Index (RSI)
- REPL 47.90
- GHM 49.79
- Support Level
- REPL $5.74
- GHM $46.58
- Resistance Level
- REPL $6.15
- GHM $49.70
- Average True Range (ATR)
- REPL 0.35
- GHM 1.77
- MACD
- REPL 0.12
- GHM 0.10
- Stochastic Oscillator
- REPL 41.03
- GHM 56.95
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About GHM Graham Corporation
Graham Corporation designs and manufactures mission-critical fluid, power, heat transfer, and vacuum technologies for the defense, space, energy, and process industries. The company also services and sells spare parts for its equipment. It designs and manufactures custom-engineered vacuum, heat transfer, cryogenic pump and turbomachinery technologies.